Surface CD152 (CTLA-4) expression and signaling dictates longevity of CD28null T cells

Journal of Immunology

Volumn 182, Issue 9, 2009, Pages 5342-5351

  Hoff, Holger ^b   Knieke, Karin ^a,b   Cabail, Zulema ^a,b   Hirseland, Heike ^b   Vratsanos, George ^c   Burmester, Gerd Rüdiger ^b   Jorch, Gerhard ^a   Nadler, Steven G ^c   Bröker, Barbara ^d   Hebel, Katrin ^a   Brunner Weinzierl, Monika C ^a,b  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c BRISTOL MYERS SQUIBB   (United States)

^d UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; CASPASE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FAS LIGAND; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAD; PROTEIN KINASE B; CD28 ANTIGEN; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CD28 NULL T LYMPHOCYTE; CELL CYCLE ARREST; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFLAMMATION; LONGEVITY; NULL CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; BIOSYNTHESIS; CELL CYCLE; CYTOLOGY; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, CD; ANTIGENS, CD28; APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES, NULL; MEMBRANE PROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS;

EID: 66949146941     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0801624     Document Type: Article

References (56)

1. - T cells in patients with rheumatoid arthritis. Arthritis Res. Ther. 5: R210-R213.
2. Lamprecht, P., F. Moosig, E. Csernok, U. Seitzer, A. Schnabel, A. Mueller, and W. L. Gross. 2001. CD28 negative T cells are enriched in granulomatous lesions of the respiratory tract in Wegener's granulomatosis. Thorax 56: 751-757. (Pubitemid 32917543)
3. Giscombe, R., S. Nityanand, N. Lewin, J. Grunewald, and A. K. Lefvert. 1998. Expanded T cell populations in patients with Wegener's granulomatosis: characteristics and correlates with disease activity. J. Clin. Immunol. 18: 404-413. (Pubitemid 28565218)
4. - costimulation-independent T cells in multiple sclerosis. J. Clin. Invest. 108: 1185-1194.
5. +CD28- T cells in ankylosing spondylitis. Arthritis Res. 4: 71-76.
6. - T cells in ankylosing spondylitis. Arthritis Res. Ther. 5: R292-R300.
7. Namekawa, T., U. G. Wagner, J. J. Goronzy, and C. M. Weyand. 1998. Functional subsets of CD4 T cells in rheumatoid synovitis. Arthritis Rheum. 41: 2108-2116. (Pubitemid 29009368)
8. Posnett, D. N., R. Sinha, S. Kabak, and C. Russo. 1994. Clonal populations of T cells in normal elderly humans: the T cell equivalent to "benign monoclonal gammapathy." J. Exp. Med. 179: 609-618.
9. + T cells is associated with the loss of gene-specific nuclear factor binding activity. J. Biol. Chem. 273: 8119-8129.
10. + cells with identical CDR3 sequences. Clin. Immunol. Immunopathol. 89: 61-70.
11. - T cells in rheumatoid arthritis. Mol. Med. 2: 608-618.
12. - subset mediates noncytolytic functional suppression. Clin. Immunol. Immunopathol. 60: 254-267.
13. - T suppressor cells and the induction of antigen-specific, antigen-presenting cell-mediated suppression of Th reactivity. Immunol. Rev. 182: 201-206.
14. - T cells. Eur. J. Immunol. 27: 1082-1090.
15. - T cells in the aging immune system. Mech. Ageing Dev. 102: 131-147.
16. Watanabe, T., Y. Sakai, A. Hanai, S. Masaki, K. Ohno, S. Miyawaki, and A. Matsuzawa. 1993. A new allele at the lpr gene on mouse chromosome 19 expresses properties different from the original recessive mutation. Mamm. Genome. 4: 346-347.
17. Lynch, D. H., M. L. Watson, M. R. Alderson, P. R. Baum, R. E. Miller, T. Tough, M. Gibson, T. vis-Smith, C. A. Smith, and K. Hunter. 1994. The mouse Fasligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1: 131-136.
18. Green, D. R., N. Droin, and M. Pinkoski. 2003. Activation-induced cell death in T cells. Immunol. Rev. 193: 70-81.
19. Lenardo, M., K. M. Chan, F. Hornung, H. McFarland, R. Siegel, J. Wang, and L. Zheng. 1999. Mature T lymphocyte apoptosis: immune regulation in a dynamic and unpredictable antigenic environment. Annu. Rev. Immunol. 17: 221-253. (Pubitemid 29241124)
20. Pinkoski, M. J., and D. R. Green. 2002. Lymphocyte apoptosis: refining the paths to perdition. Curr. Opin. Hematol. 9: 43-49.
21. Datta, S. R., A. Brunet, and M. E. Greenberg. 1999. Cellular survival: a play in three Akts. Genes Dev. 13: 2905-2927.
22. Vaux, D. L., and R. A. Flavell. 2000. Apoptosis genes and autoimmunity. Curr. Opin. Immunol. 12: 719-724.
23. Van, P. L., D. A. Peterson, and A. K. Abbas. 1998. The Fas/Fas ligand pathway and Bcl-2 regulate T cell responses to model self and foreign antigens. Immunity 8: 265-274.
24. Van, P. L., A. Biuckians, and A. K. Abbas. 1998. Functional roles of Fas and Bcl-2-regulated apoptosis of T lymphocytes. J. Immunol. 160: 2065-2071.
25. Pandiyan, P., D. Gartner, O. Soezeri, A. Radbruch, K. Schulze-Osthoff, and M. C. Brunner-Weinzierl. 2004. CD152 (CTLA-4) determines the unequal resistance of Th1 and Th2 cells against activation-induced cell death by a mechanism requiring PI3 kinase function. J. Exp. Med. 199: 831-842. (Pubitemid 38375203)
26. Chambers, C. A., M. F. Krummel, B. Boitel, A. Hurwitz, T. J. Sullivan, S. Fournier, D. Cassell, M. Brunner, and J. P. Allison. 1996. The role of CTLA-4 in the regulation and initiation of T-cell responses. Immunol. Rev. 153: 27-46. (Pubitemid 27010762)
27. Waase, I., C. Kayser, P. J. Carlson, J. J. Goronzy, and C. M. Weyand. 1996. Oligoclonal T cell proliferation in patients with rheumatoid arthritis and their unaffected siblings. Arthritis Rheum. 39: 904-913. (Pubitemid 26182057)
28. - T cells from rheumatoid arthritis patients. J. Immunol. 161: 1018-1025.
29. Lafage-Pochitaloff, M., R. Costello, D. Couez, J. Simonetti, P. Mannoni, C. Mawas, and D. Olive. 1990. Human CD28 and CTLA-4 Ig superfamily genes are located on chromosome 2 at bands q33-q34. Immunogenetics 31: 198-201. (Pubitemid 20095948)
30. Egen, J. G., M. S. Kuhns, and J. P. Allison. 2002. CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat. Immunol. 3: 611-618.
31. Brunner, M. C., C. A. Chambers, F. K. Chan, J. Hanke, A. Winoto, and J. P. Allison. 1999. CTLA-4-Mediated inhibition of early events of T cell proliferation. J. Immunol. 162: 5813-5820. (Pubitemid 29314933)
32. L induction. J. Immunol. 160: 12-15.
33. Fife, B. T., M. D. Griffin, A. K. Abbas, R. M. Locksley, and J. A. Bluestone. 2006. Inhibition of T cell activation and autoimmune diabetes using a B cell surface-linked CTLA-4 agonist. J. Clin. Invest. 116: 2252-2261.
34. Maszyna, F., H. Hoff, D. Kunkel, A. Radbruch, and M. C. Brunner-Weinzierl. 2003. Diversity of clonal T cell proliferation is mediated by differential expression of CD152 (CTLA-4) on the cell surface of activated individual T lymphocytes. J. Immunol. 171: 3459-3466. (Pubitemid 37254547)
35. Chuang, E., T. S. Fisher, R. W. Morgan, M. D. Robbins, J. M. Duerr, M. G. Vander Heiden, J. P. Gardner, J. E. Hambor, M. J. Neveu, and C. B. Thompson. 2000. The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A. Immunity 13: 313-322.
36. Baroja, M. L., L. Vijayakrishnan, E. Bettelli, P. J. Darlington, T. A. Chau, V. Ling, M. Collins, B. M. Carreno, J. Madrenas, and V. K. Kuchroo. 2002. Inhibition of CTLA-4 function by the regulatory subunit of serine/threonine phosphatase 2A. J. Immunol. 168: 5070-5078.
37. Schneider, H., K. V. Prasad, S. E. Shoelson, and C. E. Rudd. 1995. CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells. J. Exp. Med. 181: 351-355.
38. Marengere, L. E., P. Waterhouse, G. S. Duncan, H. W. Mittrucker, G. S. Feng, and T. W. Mak. 1996. Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Science 272: 1170-1173. (Pubitemid 26169471)
39. Lee, K. M., E. Chuang, M. Griffin, R. Khattri, D. K. Hong, W. Zhang, D. Straus, L. E. Samelson, C. B. Thompson, and J. A. Bluestone. 1998. Molecular basis of T cell inactivation by CTLA-4. Science 282: 2263-2266.
40. Vallejo, A. N., C. M. Weyand, and J. J. Goronzy. 2001. Functional disruption of the CD28 gene transcriptional initiator in senescent T cells. J. Biol. Chem. 276: 2565-2570. (Pubitemid 37376631)
41. Krummel, M. F., and J. P. Allison. 1996. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183: 2533-2540.
42. null T cells are associated with defects in apoptotic pathways. J. Immunol. 165: 6301-6307.
43. + T cells that reach replicative senescence after multiple rounds of antigen-specific proliferation. Exp. Gerontol. 34: 633-644.
44. Linsley, P. S., S. G. Nadler, J. Bajorath, R. Peach, H. T. Leung, J. Rogers, J. Bradshaw, M. Stebbins, G. Leytze, and W. Brady. 1995. Binding stoichiometry of the cytotoxic T lymphocyte-associated molecule-4 (CTLA-4): a disulfide-linked homodimer binds two CD86 molecules. J. Biol. Chem. 270: 15417-15424.
45. Linsley, P. S., P. M. Wallace, J. Johnson, M. G. Gibson, J. L. Greene, J. A. Ledbetter, C. Singh, and M. A. Tepper. 1992. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 257: 792-795.
46. Lenschow, D. J., Y. Zeng, J. R. Thistlethwaite, A. Montag, W. Brady, M. G. Gibson, P. S. Linsley, and J. A. Bluestone. 1992. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science 257: 789-792.
47. Grohmann, U., C. Orabona, F. Fallarino, C. Vacca, F. Calcinaro, A. Falorni, P. Candeloro, M. L. Belladonna, R. Bianchi, M. C. Fioretti, and P. Puccetti. 2002. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol. 3: 1097-1101. (Pubitemid 35363664)
48. Fallarino, F., U. Grohmann, C. Vacca, R. Bianchi, C. Orabona, A. Spreca, M. C. Fioretti, and P. Puccetti. 2002. T cell apoptosis by tryptophan catabolism. Cell Death Differ. 9: 1069-1077.
49. Vallejo, A. N., E. Bryl, K. Klarskov, S. Naylor, C. M. Weyand, and J. J. Goronzy. 2002. Molecular basis for the loss of CD28 expression in senescent T cells. J. Biol. Chem. 277: 46940-46949.
50. Linsley, P. S., J. Bradshaw, J. Greene, R. Peach, K. L. Bennett, and R. S. Mittler. 1996. Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity 4: 535-543.
51. - T cells. Hum. Immunol. 63: 1000-1009.
52. - T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J. Clin. Invest. 97: 2027-2037.
53. Hoff, H., G. R. Burmester, and M. C. Brunner-Weinzierl. 2006. Competition and cooperation: Signal transduction by CD28 and CTLA-4. Signal Transduction 6: 260-267. (Pubitemid 44238260)
54. Ndejembi, M. P., J. R. Teijaro, D. S. Patke, A. W. Bingaman, M. R. Chandok, A. Azimzadeh, S. G. Nadler, and D. L. Farber. 2006. Control of memory CD4 T cell recall by the CD28/B7 costimulatory pathway. J. Immunol. 177: 7698-7706.
55. Bluestone, J. A., E. W. St Clair, and L. A. Turka. 2006. CTLA4Ig: bridging the basic immunology with clinical application. Immunity 24: 233-238.
56. Kremer, J. M., R. Westhovens, M. Leon, G. E. Di, R. Alten, S. Steinfeld, A. Russell, M. Dougados, P. Emery, I. F. Nuamah, et al. 2003. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N. Engl. J. Med. 349: 1907-1915.